Subclinical Cardiac Involvement in Patients With Inflamatory Bowel Disease
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 200
- 主要终点
- determine the prevelance of cardiac involvement in inflamatory bowel disease
研究概览
简要总结
Aim of the study is to determine the prevelance of subclinical cardiac involvement in patients with inflamatory bowel disease.
详细描述
Cardiovascular manifestations in patients with IBD mostly occur as immune-related consequences and include the following: pericarditis, myocarditis, venous and arterial thromboembolism, left ventricle impairment, arrhythmias and conduction disorders and valvulopathy .
The prevalence of classical cardiovascular risk factors is relatively lower in IBD patients than in the general population . However, the risk of coronary heart disease is higher in IBD patients .
The pathophysiology of cardiac involvement may be Systemic inflammation for prolonged periods that can cause platelet aggregation and endothelial dysfunction leading to the development of atherosclerosis and CVD .
The chronic inflammatory condition found in IBD is the key element in the pathogenesis of arrhythmias.
In IBD, inflammation causes mitral and aortic valvulopathies , excess TNF-α causes the thickening and shortening of the leaflets, resulting in regurgitation .
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 18 Years 至 80 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Inflamatory bowel disease patients without previous history of cardiac disease.
排除标准
- •Patients known to have previous cardiac disease.
结局指标
主要结局
determine the prevelance of cardiac involvement in inflamatory bowel disease
时间窗: Baseline
Assesment of cardiac involvement in inflamatory bowel disease byECG,HolterECG andEchocardiography
次要结局
未报告次要终点
研究者
Hossam Eldin Mohammed Essam Abdelhafez
Subclinical cardiac involvement in patients with inflamatory bowel disease
Assiut University
